Daniel Lammertse
Corporate Officer/Principal chez Xalud Therapeutics, Inc.
Provenance du réseau au premier degré de Daniel Lammertse
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA.
9
| Holding Company | Biotechnology | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Daniel Lammertse via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer Director/Board Member | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Private Equity Investor Chief Executive Officer | |
| Vetana Animal Health, Inc. | Chairman Director/Board Member | ||
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Chief Executive Officer Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree | |
| PRECIGEN, INC. | Biotechnology | Private Equity Investor | |
| Rollins College (Florida) | College/University | Undergraduate Degree | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member | |
| Pbm Capital Investments LLC | Chief Executive Officer | ||
| Brown University | College/University | Undergraduate Degree | |
Benevolent Capital Partners LLC (Private Equity)
 Benevolent Capital Partners LLC (Private Equity) Investment ManagersFinance Benevolent Capital Partners LLC (Private Equity) (Benevolent Capital) is a private equity and venture capital firm founded in 2005 by Brett M. Johnson and Grant D. Johnson. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Founder | |
| Ravelin Capital Group LLC | Corporate Officer/Principal | ||
NatWest Markets Securities, Inc.
 NatWest Markets Securities, Inc. Investment Banks/BrokersFinance Founded in 1985, NatWest Markets Securities, Inc. is a financial services and brokerage firm headquartered in Stamford, Connecticut. The firm is a subsidiary of RBS Holdings USA, Inc. and their ultimate parent is the Royal Bank of Scotland Plc (LSE: RBS). The firm was formerly known as RBS Securities, Inc., RBS Greenwich Capital, and Greenwich Capital Markets, Inc. NatWest is an institutional fixed-income firm that provides a full range of debt capital markets services to both those seeking to raise capital and those seeking to invest it. The firm is an industry leader in the U.S. Treasury, agency and MBS markets and in providing real estate and asset-backed financing to their clients. NatWest also provides futures brokerage services and trade strategies to select clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
| CS First Boston Pacific, Inc. | Corporate Officer/Principal | ||
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Octagon Partners LLC | Corporate Officer/Principal | ||
Octagon Finance LLC
 Octagon Finance LLC Financial ConglomeratesFinance Octagon Finance LLC provides financial services. The private company is based in Durham. | Financial Conglomerates | Corporate Officer/Principal | |
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| Baxis Pharmaceuticals, Inc. | Director/Board Member | ||
| Novartis Gene Therapies Switzerland GmbH | Director/Board Member | ||
University of Virginia Community Credit Union
 University of Virginia Community Credit Union Savings BanksFinance University of Virginia Community Credit Union operates as a state chartered credit union. The private company is based in Charlottesville, VA and has subsidiaries in the United States. | Savings Banks | Corporate Officer/Principal | |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | Director/Board Member | |
PatientsLikeMe LLC
 PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA. | Internet Software/Services | Director/Board Member | |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Director/Board Member | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Biscayne Pharmaceuticals, Inc.
 Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL. | Pharmaceuticals: Major | Chief Executive Officer | |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 48 |
| Norvège | 2 |
| Suisse | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 9 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 44 |
| Corporate Officer/Principal | 21 |
| Independent Dir/Board Member | 8 |
| Chairman | 8 |
| Chief Executive Officer | 7 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sean Stalfort | 28 |
| Paul Manning | 26 |
| Stephen D. Collins | 16 |
| Jayson M. Rieger | 10 |
| Mike Huston | 1 |
| Brendan O’Leary | 1 |
| Charles Cleeland | 1 |
| Ronald Dubner | 1 |
| Gerald Gebhart | 1 |
- Bourse
- Insiders
- Daniel Lammertse
- Connexions Sociétés
